⌘K (Command K) to search

Sign in Sign up free

8-KAccepted Jan 24, 4:00 PM ET

BELLICUM PHARMACEUTICALS, INC 8-K

BELLICUM PHARMACEUTICALS, INC

sec.gov View full filing

Accepted (ET)

4:00 PM

Jan 24, 2024

Filed

Jan 24, 2024

Documents

14

Size

244.4 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.

Filing details

Company: BELLICUM PHARMACEUTICALS, INC
CIK: 0001358403
Form: 8-K
Accepted: Jan 24, 4:00 PM ET
Filed: Jan 24, 2024
Size: 244.4 KB
Accession: 0001539497-24-000104

Documents · 14

n3936_x2-8k.htmPrimary
8-K
exh3-1.htm
CERTIFICATE OF DESIGNATION OF SENIOR A JUNIOR PREFERRED STOCK OF BELLICUM PHARMACEUTICALS, INC., DATED JANUARY 24, 2024
exh3-2.htm
AMENDMENT TO AMENDED AND RESTATED BYLAWS OF BELLICUM PHARMACEUTICALS, INC., EFFECTIVE JANUARY 24, 2024
blcm-20240124.xsd
XBRL SCHEMA FILE
blcm-20240124_lab.xml
XBRL LABEL FILE
blcm-20240124_pre.xml
XBRL PRESENTATION FILE
R1.htm
IDEA: XBRL DOCUMENT
n3936_x2-8k_htm.xml
IDEA: XBRL DOCUMENT
Financial_Report.xlsx
IDEA: XBRL DOCUMENT
Show.js
IDEA: XBRL DOCUMENT
report.css
IDEA: XBRL DOCUMENT
FilingSummary.xml
IDEA: XBRL DOCUMENT
MetaLinks.json
IDEA: XBRL DOCUMENT
0001539497-24-000104-xbrl.zip
IDEA: XBRL DOCUMENT